Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for ...

This approval positions Lupin to tap into a substantial market opportunity for a drug indicated for the treatment of ...

Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

The shares of Indian pharmaceutical company Lupin rose 2.6% to their day’s high of Rs 2,081.95 on the BSE on Monday, March 10, after the company launched its Rivaroxaban Tablets USP, 2.5mg in ...

Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg. This product would be ...

The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication ...

Global pharma major Lupin Limited (Lupin) announced that it has launched rivaroxaban tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application from the US FDA.